Temozolomide is an oral chemotherapy medicine used for specific types of brain tumors. It works as an alkylating agent, interfering with DNA in cancer cells and helping prevent them from growing and dividing. It is an established treatment option for conditions such as glioblastoma and anaplastic astrocytoma.
The medicine may be prescribed alone or as part of a combination treatment plan, including treatment alongside radiotherapy, depending on the patient's diagnosis and oncology protocol.
Temozolomide is primarily associated with the treatment of certain high-grade brain tumors, particularly glioblastoma and anaplastic astrocytoma. Its exact indication depends on the patient's diagnosis, tumor characteristics and treatment history.
Temozolomide damages the DNA of susceptible cancer cells. This interferes with their ability to replicate and can contribute to cancer-cell death.
Temozolomide should be taken exactly according to the oncologist's prescription. The dose and treatment schedule are individualized according to factors such as the cancer type, treatment phase, body-surface area and other medicines being used.
Original medicine receive hui aur delivery time par thi. Service se satisfied hun